{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:13:08Z","timestamp":1754485988023},"reference-count":49,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2020]]},"DOI":"10.1620\/tjem.252.321","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T22:08:10Z","timestamp":1606860490000},"page":"321-327","source":"Crossref","is-referenced-by-count":2,"title":["Sight-Threatening Graves\u2019 Ophthalmopathy during the Third Trimester of Pregnancy: A Case Report"],"prefix":"10.1620","volume":"252","author":[{"given":"Kanako","family":"Sakurai","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Sendai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshu","family":"Inoue","sequence":"additional","affiliation":[{"name":"Olympia Eye Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Niitsuma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Sendai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Sendai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenei","family":"Arihara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Sendai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Abbouda, A., Trimboli, P. &amp; Bruscolini, A. (2014)  A mild Grave\u2019s ophthalmopathy during pregnancy.  <i>Semin. Ophthalmol.<\/i>, 29, 8-10."},{"key":"2","unstructured":"Alkawas, A.A., Hussein, A.M. &amp; Shahien, E.A. (2010)  Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy.  <i>Clin. Exp. Ophthalmol.<\/i>, 38, 692-697."},{"key":"3","unstructured":"Allannic, H., Fauchet, R., Orgiazzi, J., Madec, A.M., Genetet, B., Lorcy, Y., Le Guerrier, A.M., Delambre, C. &amp; Derennes, V. (1990)  Antithyroid drugs and Graves\u2019 disease: a prospective randomized evaluation of the efficacy of treatment duration.  <i>J. Clin. Endocrinol. Metab.<\/i>, 70, 675-679."},{"key":"4","unstructured":"Anderson, G.G., Rotchell, Y. &amp; Kaiser, D.G. (1981)  Placental transfer of methylprednisolone following maternal intravenous administration.  <i>Am. J. Obstet. Gynecol.<\/i>, 140, 699-701."},{"key":"5","unstructured":"Bahn, R.S. (2010)  Graves\u2019 ophthalmopathy.  <i>N. Engl. J. Med.<\/i>, 362, 726-738."},{"key":"6","unstructured":"Bartalena, L., Baldeschi, L., Dickinson, A., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M., Perros, P., Boboridis, K., Boschi, A., Curr\u00f2, N., Daumerie, C., Kahaly, G.J., Krassas, G.E., Lane, C.M., et al.  (2008)  Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO.  <i>Eur. J. Endocrinol.<\/i>, 158, 273-285."},{"key":"7","unstructured":"Bartalena, L., Pinchera, A. &amp; Marcocci, C. (2000)  Management of Graves\u2019 ophthalmopathy: reality and perspectives.  <i>Endocr. Rev.<\/i>, 21, 168-199."},{"key":"8","unstructured":"Bartalena, L. &amp; Tanda, M.L. (2009)  Clinical practice.  Graves\u2019 ophthalmopathy.  <i>N. Engl. J. Med.<\/i>, 360, 994-1001."},{"key":"9","unstructured":"Bech, K. &amp; Nistrup Madsen, S. (1980)  Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves\u2019 disease.  <i>Clin. Endocrinol. <\/i>(<i>Oxf.<\/i>), 13, 417-424."},{"key":"10","unstructured":"Beitins, I.Z., Bayard, F., Ances, I.G., Kowarski, A. &amp; Migeon, C.J. (1972)  The transplacental passage of prednisone and prednisolone in pregnancy near term.  <i>J. Pediatr.<\/i>, 81, 936-945."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Bordaberry, M., Marques, D.L., Pereira-Lima, J.C., Marcon, I.M. &amp; Schmid, H. (2009)  Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves\u2019 ophthalmopathy.  <i>Acta Ophthalmol.<\/i>, 87, 58-64.","DOI":"10.1111\/j.1755-3768.2008.01171.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Brown, R.W., Chapman, K.E., Edwards, C.R. &amp; Seckl, J.R. (1993)  Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform.  <i>Endocrinology<\/i>, 132, 2614-2621.","DOI":"10.1210\/endo.132.6.8504762"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Brown, R.W., Diaz, R., Robson, A.C., Kotelevtsev, Y.V., Mullins, J.J., Kaufman, M.H. &amp; Seckl, J.R. (1996)  The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development.  <i>Endocrinology<\/i>, 137, 794-797.","DOI":"10.1210\/endo.137.2.8593833"},{"key":"14","unstructured":"Burch, H.B. &amp; Wartofsky, L. (1993)  Graves\u2019 ophthalmopathy: current concepts regarding pathogenesis and management.  <i>Endocr. Rev.<\/i>, 14, 747-793."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Dolman, P.J. (2020)  Dysthyroid optic neuropathy: evaluation and management.  <i>J. Endocrinol. Invest.<\/i>, doi: 10.1007\/s40618-020-01361-y.  [Epub ahead of print].","DOI":"10.1007\/s40618-020-01361-y"},{"key":"16","unstructured":"Ebner, R., Devoto, M.H., Weil, D., Bordaberry, M., Mir, C., Martinez, H., Bonelli, L. &amp; Niepomniszcze, H. (2004)  Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.  <i>Br. J. Ophthalmol.<\/i>, 88, 1380-1386."},{"key":"17","unstructured":"Eckstein, A.K., Plicht, M., Lax, H., Neuh\u00e4user, M., Mann, K., Lederbogen, S., Heckmann, C., Esser, J. &amp; Morgenthaler, N.G. (2006)  Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease.  <i>J. Clin. Endocrinol. Metab.<\/i>, 91, 3464-3470."},{"key":"18","unstructured":"Ford, H.C., Feek, C.M. &amp; Delahunt, J.W. (1991)  Once daily, low dose, short term antithyroid drug treatment of Graves\u2019 disease is followed by an unacceptably high relapse rate.  <i>NZ Med. J.<\/i>, 104, 97-98."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Gebertt, S. (1961)  Depot-methylprednisolone for subconjunctival and retrobulbar injections.  <i>Lancet<\/i>, 2, 344-345.","DOI":"10.1016\/S0140-6736(61)90636-5"},{"key":"20","unstructured":"Goldberg, R.A. (2004)  Orbital steroid injections.  <i>Br. J. Ophthalmol.<\/i>, 88, 1359-1360."},{"key":"21","unstructured":"Guller, S., Kong, L., Wozniak, R. &amp; Lockwood, C.J. (1995)  Reduction of extracellular matrix protein expression in human amnion epithelial cells by glucocorticoids: a potential role in preterm rupture of the fetal membranes.  <i>J. Clin. Endocrinol. Metab.<\/i>, 80, 2244-2250."},{"key":"22","doi-asserted-by":"crossref","unstructured":"Hiromatsu, Y., Sato, M., Inoue, Y., Koga, M., Miyake, I., Kameo, J., Tokisawa, S., Yang, D. &amp; Nonaka, K. (1996)  Localization and clinical significance of thyrotropin receptor mRNA expression in orbital fat and eye muscle tissues from patients with thyroid-associated ophthalmopathy.  <i>Thyroid<\/i>, 6, 553-562.","DOI":"10.1089\/thy.1996.6.553"},{"key":"23","unstructured":"Kozaki, A., Nakamura, H., Inoue, R. &amp; Inoue, T. (2014)  Dysthyroid optic neuropathy in pregnancy.  <i>Nippon Ganka Gakkai Zasshi<\/i>, 118, 433-439."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Le Moli, R., Baldeschi, L., Saeed, P., Regensburg, N., Mourits, M.P. &amp; Wiersinga, W.M. (2007)  Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves\u2019 ophthalmopathy.  <i>Thyroid<\/i>, 17, 357-362.","DOI":"10.1089\/thy.2006.0267"},{"key":"25","unstructured":"Levitz, M., Jansen, V. &amp; Dancis, J. (1978)  The transfer and metabolism of corticosteroids in the perfused human placenta.  <i>Am. J. Obstet. Gynecol.<\/i>, 132, 363-366."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Lockwood, C.J., Radunovic, N., Nastic, D., Petkovic, S., Aigner, S. &amp; Berkowitz, G.S. (1996)  Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy.  <i>J. Perinat. Med.<\/i>, 24, 243-251.","DOI":"10.1515\/jpme.1996.24.3.243"},{"key":"27","unstructured":"Lytton, S.D., Ponto, K.A., Kanitz, M., Matheis, N., Kohn, L.D. &amp; Kahaly, G.J. (2010)  A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves\u2019orbitopathy.  <i>J. Clin. Endocrinol. Metab.<\/i>, 95, 2123-2131."},{"key":"28","unstructured":"Marcocci, C., Bartalena, L., Bogazzi, F., Panicucci, M. &amp; Pinchera, A. (1989)  Studies on the occurrence of ophthalmopathy in Graves\u2019 disease.  <i>Acta Endocrinol. <\/i>(<i>Copenh.<\/i>), 120, 473-478."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Marin\u00f3, M., Morabito, E., Brunetto, M.R., Bartalena, L., Pinchera, A. &amp; Marocci, C. (2004)  Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves\u2019 ophthalmopathy.  <i>Thyroid<\/i>, 14, 403-406.","DOI":"10.1089\/105072504774193276"},{"key":"30","unstructured":"McGregor, A.M., Petersen, M.M., McLachlan, S.M., Rooke, P., Smith, B.R. &amp; Hall, R. (1980)  Carbimazole and the autoimmune response in Graves\u2019 disease.  <i>N. Engl. J. Med.<\/i>, 303, 302-307."},{"key":"31","unstructured":"Mestman, J.H., Goodwin, T.M. &amp; Montoro, M.M. (1995)  Thyroid disorders of pregnancy.  <i>Endocrinol. Metab. Clin. North Am.<\/i>, 24, 41-71."},{"key":"32","unstructured":"N\u00fcssgens, Z., Roggenk\u00e4mper, P. &amp; Schweikert, H.U. (1993)  Development of endocrine orbitopathy in pregnancy.  <i>Klin. Monbl. Augenheilkd.<\/i>, 202, 130-133."},{"key":"33","doi-asserted-by":"crossref","unstructured":"Noh, J.Y., Hamada, N., Inoue, Y., Abe, Y., Ito, K. &amp; Ito, K. (2000)  Thyroid-stimulating antibody is related to Graves\u2019 ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves\u2019 disease.  <i>Thyroid<\/i>, 10, 809-813.","DOI":"10.1089\/thy.2000.10.809"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Park-Wyllie, L., Mazzotta, P., Pastuszak, A., Moretti, M.E., Beique, L., Hunnisett, L., Friesen, M.H., Jacobson, S., Kasapinovic, S., Chang, D., Diav-Citrin, O., Chitayat, D., Nulman, I., Einarson, T.R. &amp; Koren, G. (2000)  Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.  <i>Teratology<\/i>, 62, 385-392.","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z"},{"key":"35","unstructured":"Reinwein, D., Benker, G., Lazarus, J.H. &amp; Alexander, W.D. (1993)  A prospective randomized trial of antithyroid drug dose in Graves\u2019 disease therapy.  European Multicenter Study Group on Antithyroid Drug Treatment.  <i>J. Clin. Endocrinol. Metab.<\/i>, 76, 1516-1521."},{"key":"36","unstructured":"Reynolds, R.M. (2013)  Programming effects of glucocorticoids.  <i>Clin. Obstet. Gynecol.<\/i>, 56, 602-609."},{"key":"37","unstructured":"Romaldini, J.H., Bromberg, N., Werner, R.S., Tanaka, L.M., Rodrigues, H.F., Werner, M.C., Farah, C.S. &amp; Reis, L.C. (1983)  Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves\u2019 hyperthyroidism.  <i>J. Clin. Endocrinol. Metab.<\/i>, 57, 563-570."},{"key":"38","unstructured":"Rotondi, M., Cappelli, C., Pirali, B., Pirola, I., Magri, F., Fonte, R., Castellano, M., Rosei, E.A. &amp; Chiovato, L. (2008)  The effect of pregnancy on subsequent relapse from Graves\u2019 disease after a successful course of antithyroid drug therapy.  <i>J. Clin. Endocrinol. Metab.<\/i>, 93, 3985-3988."},{"key":"39","unstructured":"Stafford, I.P., Dildy, G.A. 3rd &amp; Miller, J.M. Jr. (2005)  Severe Graves\u2019 ophthalmopathy in pregnancy.  <i>Obstet. Gynecol.<\/i>, 105, 1221-1223."},{"key":"40","unstructured":"Tamai, H., Nakagawa, T., Fukino, O., Ohsako, N., Shinzato, R., Suematsu, H., Kuma, K., Matsuzuka, F. &amp; Nagataki, S. (1980)  Thionamide therapy in Graves\u2019 disease: relation of relapse rate to duration of therapy.  <i>Ann. Intern. Med.<\/i>, 92, 488-490."},{"key":"41","unstructured":"Thomas, I.D. &amp; Hart, J.K. (1974)  Retrobulbar repository corticosteroid therapy in thyroid ophthalmopathy.  <i>Med. J. Aust.<\/i>, 2, 484-487."},{"key":"42","unstructured":"Thorp, J.A., Jones, P.G., Knox, E. &amp; Clark, R.H. (2002)  Does antenatal corticosteroid therapy affect birth weight and head circumference? <i>Obstet. Gynecol.<\/i>, 99, 101-108."},{"key":"43","unstructured":"Tramunt, B., Imbert, P., Grunenwald, S., Boutault, F. &amp; Caron, P. (2019)  Sight-threatening Graves\u2019 orbitopathy: twenty years\u2019 experience of a multidisciplinary thyroid-eye outpatient clinic.  <i>Clin. Endocrinol. <\/i>(<i>Oxf.<\/i>), 90, 208-213."},{"key":"44","unstructured":"Wall, J.R., Lahooti, H., Hibbert, E.J. &amp; Champion, B. (2015)  Relationship between clinical and immunological features of thyroid autoimmunity and ophthalmopathy during pregnancy.  <i>J. Thyroid Res.<\/i>, 2015, 698470."},{"key":"45","unstructured":"Weetman, A.P., McGregor, A.M. &amp; Hall, R. (1984)  Evidence for an effect of antithyroid drugs on the natural history of Graves\u2019 disease.  <i>Clin. Endocrinol. <\/i>(<i>Oxf.<\/i>), 21, 163-172."},{"key":"46","doi-asserted-by":"crossref","unstructured":"Weetman, A.P., Tandon, N. &amp; Morgan, B.P. (1992)  Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells.  <i>Lancet<\/i>, 340, 633-636.","DOI":"10.1016\/0140-6736(92)92171-B"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Weissel, M. &amp; Hauff, W. (2000)  Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease.  <i>Thyroid<\/i>, 10, 521.","DOI":"10.1089\/thy.2000.10.521"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Wiersinga, W.M. &amp; Bartalena, L. (2002)  Epidemiology and prevention of Graves\u2019 ophthalmopathy.  <i>Thyroid<\/i>, 12, 855-860.","DOI":"10.1089\/105072502761016476"},{"key":"49","unstructured":"Zang, S., Ponto, K.A. &amp; Kahaly, G.J. (2011)  Clinical review: intravenous glucocorticoids for Graves\u2019 orbitopathy: efficacy and morbidity.  <i>J. Clin. Endocrinol. Metab.<\/i>, 96, 320-332."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/252\/4\/252_321\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T04:03:56Z","timestamp":1610165036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/252\/4\/252_321\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.252.321","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}